Results 91 to 100 of about 16,675 (216)

Overview of Antabuse® (Disulfiram) in Radiation and Cancer Biology

Cancer Management and Research, 2021
Yaqi Jia, Tao Huang Department of Hepatobiliary Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaCorrespondence: Tao HuangDepartment of Hepatobiliary Surgery, The Affiliated Cancer Hospital of ...
Jia Y, Huang T
doaj  

Assessing Major Adverse Liver Outcomes With Baclofen Compared to Acamprosate in Compensated Alcohol‐Associated Cirrhosis

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 12, Page 1673-1684, June 2026.
We conducted a nationwide, multicenter cohort study using a target trial emulation framework to compare baclofen and acamprosate in patients with compensated alcohol‐associated cirrhosis. After matching, baclofen initiation was associated with a higher 1‐year risk of major adverse liver outcomes, driven primarily by hepatic encephalopathy, particularly
Yee Hui Yeo, Sepideh Mehravar, Ellen Choi, Ju Dong Yang, Hyun‐Seok Kim, Yun Wang, Aarshi Vipani, Hirsh D. Trivedi, Walid Ayoub, Parnian Naji, Alexander Kuo, Chun‐Ying Wu, Lorenzo Leggio, Juan Pablo Arab   +13 more
wiley   +1 more source

A study of cardiovascular complications of disulfiram-ethanol reaction

National Journal of Physiology, Pharmacy and Pharmacology, 2013
Background: Alcohol abuse is a chronic behavioral problem that can further develop as a progressive disease. Disulfiram is the most extensively used deterrent drug for clinical management of alcoholism. A supervised disulfiram-ethanol reaction (DER) test
Girish Kumaraswamy, Pundarikaksha HP, Vijendra Ramaiah, Jagadish Anjanappa   +3 more
doaj   +1 more source

Regulated Cell Death in Idiopathic Pulmonary Fibrosis

The FASEB Journal, Volume 40, Issue 9, 15 May 2026.
This graphical abstract illustrates regulated cell death (RCD) across key pulmonary cell types—including alveolar epithelial cells, fibroblasts, macrophages, and endothelial cells—modulated through a dynamic death modulation network within the IPF microenvironment.
Xiaoyue Pan, Liu Yang, Man Zhao, Yanlin Zhou, Cong Xia, Huibing Liu, Yuqi Wang, Hui Lian, Bin Li, Lan Wang, Guoying Yu   +10 more
wiley   +1 more source

Epileptic Seizure after Disulfiram Treatment: A Case Report

Neuropsychiatric Investigation, 2019
Disulfiram is a pharmacological agent which is used for the treatment of  alcohol use disorder. Toxic reactions may be occur if it used with alcohol. The using of disulfiram without alcohol can make adverse affects like fatigue, liver toxicity, optic ...
Deniz Deniz Özturan, Zeynep Bebek Yılmaz, Merve Bilgin Koçak, Fatma Çoker   +3 more
doaj   +1 more source

Disulfiram reaction [PDF]

Halo 194, 2019
Disulfiram is a drug used for treating chronic alcoholism. The disulfiram-ethanol reaction is a result of increased blood levels of acetaldehyde, which is the product of alcohol dehydrogenase induced ethanol oxidation in the liver.
Banjac Nada, Dojčinović Boris
doaj  

First case report of cefmetazole-induced disulfiram-like reaction

IDCases
Disulfiram-like reactions occur when alcohol is consumed concurrently with certain drugs and can sometimes be fatal. Some cephalosporins such as cefoperazone could cause disulfiram-like reaction, known as cephalosporin-induced disulfiram-like reactions ...
Toshiyuki Nakanishi, Taku Harada, Mori Nakai, Satoshi Kutsuna   +3 more
doaj   +1 more source

Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence. [PDF]

iScience
Benkő BM, De Brito Parreirinha NS, Sebe I, Zelkó R.   +3 more
europepmc   +1 more source

Case Report: Disulfiram-induced optic neuropathy. [PDF]

Front Neurol
Mendes J, Fischer A, Mortensen PW, Jaiswal S, Arogundade E, Newman NJ, Lee AG.   +6 more
europepmc   +1 more source

Case report: Acamprosate for treatment of volatile hydrocarbon (VHC) inhalant use disorder with comorbid alcohol use disorder. [PDF]

Ment Health Clin
Piri N, Campbell W.
europepmc   +1 more source